Table 1 Multivariate survival analysis.

From: CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α

Variables

HR

95.0% CI for HR

P

Lower

Upper

Age, years (<55 vs. ≥55)

1.45

0.87

2.42

0.15

Stage (I/II vs. III/IV)

0.13

0.04

0.39

0.00

Grade (well vs. poor)

1.36

0.82

2.24

0.23

Ascites (No vs. Yes)

0.84

0.47

1.50

0.55

Metastases (Negative vs. Positive)

2.65

0.99

7.03

0.05

CRABP2 (Low vs. High)

2.26

1.27

4.04

0.01

Back to article page